Detailed price information for Fennec Pharmaceuticals Inc (FRX-T) from The Globe and Mail including charting and trades.

Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...

Deriving the right royalty rate for new pharmaceuticals and biotechnologies ... The idea is to compare the price differential between proprietary drugs (brand names under patent protection ...

Leveraging Northway Biotech's 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for hormone-driven ovarian cancer WALTHAM, MASSACHUSETTS / ACCESS Newswire / May 21, ...

President Trump proposed an executive order to lower the cost of prescription drugs for those on Medicare. Could it also ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

US: In a stern regulatory move, the United States Food and Drug Administration (USFDA) has issued a warning letter to ...

This course will explore the complex variety of transactions that takes place between the development and manufacturing of a pharmaceutical product and financial mechanisms that influence the payer, ...

The price trend for Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) has been bearish lately and the stock has lost 8.5% ...

America's pharmaceutical founding fathers Meanwhile ... clearly cementing the difference between production of scientific prescription medicines and other chemicals. The FDA's Frances O Kelsey ...